1. Home
  2. SSRM vs KRYS Comparison

SSRM vs KRYS Comparison

Compare SSRM & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SSR Mining Inc.

SSRM

SSR Mining Inc.

HOLD

Current Price

$28.10

Market Cap

6.5B

Sector

Industrials

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$248.06

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSRM
KRYS
Founded
1946
2015
Country
United States
United States
Employees
2900
N/A
Industry
Precious Metals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
7.8B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
SSRM
KRYS
Price
$28.10
$248.06
Analyst Decision
Buy
Strong Buy
Analyst Count
4
10
Target Price
$31.49
$297.60
AVG Volume (30 Days)
4.3M
254.5K
Earning Date
01-01-0001
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
128.00
EPS
N/A
6.84
Revenue
N/A
$389,130,000.00
Revenue This Year
$58.93
$40.88
Revenue Next Year
$6.60
$35.16
P/E Ratio
$14.37
$36.71
Revenue Growth
N/A
33.94
52 Week Low
$8.65
$123.03
52 Week High
$33.49
$298.30

Technical Indicators

Market Signals
Indicator
SSRM
KRYS
Relative Strength Index (RSI) 47.25 38.23
Support Level $27.80 $233.64
Resistance Level $28.81 $248.60
Average True Range (ATR) 1.73 9.14
MACD -0.45 -2.19
Stochastic Oscillator 6.33 9.64

Price Performance

Historical Comparison
SSRM
KRYS

About SSRM SSR Mining Inc.

SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: